3.1m buy, page-5

I don't really know what news to expect. One would expect some sort of update on the SPP; a partner for ATC or news on Tibotec. Now, Tibotec has me puzzled about the potential there.

Recently, I've discovered that Gilead & Tibotec are in an agreement to produce a second once only daily HIV pill, already in Phase 111 trials, expected to market in 2011, market worth $bns. Tibotec's TM 278 that goes in the pill seems to be inextricably linked with Avx's integrase inhibitor(s) as Avx's inhibitor(s) are better(?). Is this roughly correct?


http://www.genengnews.com/news/bnitem.aspx?name=58398425